Lymphoma Clinical Trials

Showing 2501-2520 of 3,379 trials

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

NCT02276248

This study is to evaluate the efficacy and safety of radiotherapy combined with GDP (gemcitabine, cisplatin, dexamethasone) chemotherapy in stage I/II extranodal natural killer/T-cell lymphoma patients with unfavorable prognostic factors.

Stage I/II Extranodal NK/T-cell Lymphoma

Chinese Academy of Medical Sciences40 participantsStarted Jun 2010

Beijing, Beijing Municipality, China

COMPLETEDPhase 3

A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

NCT01144364

This study will evaluate the efficacy and safety of brief induction therapy with a chemotherapeutic regimen containing MabThera, followed by either maintenance therapy with MabThera or no further therapy. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.

Non-Hodgkin's Lymphoma

Hoffmann-La Roche234 participantsStarted Jan 2004

Pescara, Abruzzo, Italy • Bari, Apulia, Italy • San Giovanni Rotondo, Apulia, Italy +42 more locations

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)

Related Searches

A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation

Thalidomide Maintenance Treatment in DLBCL

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies

CAre of Patients With PArenteral Nutrition At Home

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia